Medeon Biodesign, Inc. (TPEX:6499)

Medeon Biodesign Statistics

Total Valuation

TPEX:6499 has a market cap or net worth of TWD 9.04 billion. The enterprise value is 8.00 billion.

Market Cap	9.04B
Enterprise Value	8.00B

Important Dates

The next estimated earnings date is Friday, May 8, 2026.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:6499 has 96.94 million shares outstanding. The number of shares has increased by 0.21% in one year.

Current Share Class	96.94M
Shares Outstanding	96.94M
Shares Change (YoY)	+0.21%
Shares Change (QoQ)	+0.56%
Owned by Insiders (%)	11.70%
Owned by Institutions (%)	2.47%
Float	54.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	21.57
PB Ratio	5.89
P/TBV Ratio	6.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-11.97
EV / Sales	19.07
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-12.39

Financial Position

The company has a current ratio of 8.21, with a Debt / Equity ratio of 0.07.

Current Ratio	8.21
Quick Ratio	7.87
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	-0.18
Interest Coverage	-196.23

Financial Efficiency

Return on equity (ROE) is -46.82% and return on invested capital (ROIC) is -26.93%.

Return on Equity (ROE)	-46.82%
Return on Assets (ROA)	-24.69%
Return on Invested Capital (ROIC)	-26.93%
Return on Capital Employed (ROCE)	-44.63%
Weighted Average Cost of Capital (WACC)	8.63%
Revenue Per Employee	10.75M
Profits Per Employee	-17.13M
Employee Count	39
Asset Turnover	0.23
Inventory Turnover	12.24

Taxes

Income Tax	-352,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +93.37% in the last 52 weeks. The beta is 0.81, so TPEX:6499's price volatility has been lower than the market average.

Beta (5Y)	0.81
52-Week Price Change	+93.37%
50-Day Moving Average	94.60
200-Day Moving Average	103.21
Relative Strength Index (RSI)	46.57
Average Volume (20 Days)	1,784,027

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6499 had revenue of TWD 419.43 million and -668.06 million in losses. Loss per share was -7.24.

Revenue	419.43M
Gross Profit	58.83M
Operating Income	-722.51M
Pretax Income	-719.69M
Net Income	-668.06M
EBITDA	-666.44M
EBIT	-722.51M
Loss Per Share	-7.24

Balance Sheet

The company has 1.22 billion in cash and 113.05 million in debt, with a net cash position of 1.11 billion or 11.42 per share.

Cash & Cash Equivalents	1.22B
Total Debt	113.05M
Net Cash	1.11B
Net Cash Per Share	11.42
Equity (Book Value)	1.54B
Book Value Per Share	15.22
Working Capital	1.16B

Cash Flow

In the last 12 months, operating cash flow was -629.14 million and capital expenditures -16.47 million, giving a free cash flow of -645.61 million.

Operating Cash Flow	-629.14M
Capital Expenditures	-16.47M
Depreciation & Amortization	56.08M
Net Borrowing	-52.89M
Free Cash Flow	-645.61M
FCF Per Share	-6.66

Margins

Gross margin is 14.03%, with operating and profit margins of -172.26% and -159.28%.

Gross Margin	14.03%
Operating Margin	-172.26%
Pretax Margin	-171.59%
Profit Margin	-159.28%
EBITDA Margin	-158.89%
EBIT Margin	-172.26%
FCF Margin	n/a

Dividends & Yields

TPEX:6499 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.21%
Shareholder Yield	-0.21%
Earnings Yield	-7.39%
FCF Yield	-7.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 23, 2023. It was a forward split with a ratio of 1.049992864.

Last Split Date	Aug 23, 2023
Split Type	Forward
Split Ratio	1.049992864

Scores

TPEX:6499 has an Altman Z-Score of 17.81 and a Piotroski F-Score of 3.

Altman Z-Score	17.81
Piotroski F-Score	3